
Health Care
Elevai Labs, Inc.
ELAB
Since
Headquarters:
CA, United States
Exchange:
NASDAQ
Industry:
Biotechnology
Number of Employees:
18.00
Current Fiscal Year:
2024
Market Cap:
7.04M
Price per Share:
$2.29
Quarterly Dividend per Share:
Year-to-date Performance:
-86.8088%
Dividend Yield:
%
Price-to-book Ratio:
0.82
Trailing P/E Ratio:
N/A
Price History
Latest Prices
Date | Open | High | Low | Close |
---|---|---|---|---|
2025-04-30 | 2.34 | 2.45 | 2.14 | 2.29 |
2025-04-29 | 2.35 | 2.41 | 2.25 | 2.34 |
2025-04-28 | 2.28 | 2.3795 | 2.16 | 2.28 |
2025-04-25 | 2.26 | 2.71 | 2.21 | 2.26 |
2025-04-24 | 2.93 | 2.95 | 2.15 | 2.22 |
Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States. The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs Inc. was incorporated in 2020 and is based in Newport Beach, California.